The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Validation of PHQ-2 and PHQ-9 to Screen for Major Depression in the Primary Care Population
Open accessAbstract
PURPOSE: Although screening for unipolar depression is controversial, it is potentially an efficient way to find undetected cases and improve diagnostic acumen. Using a reference standard, we aimed to validate the 2- and 9-question Patient Health Questionnaires (PHQ-2 and PHQ-9) in primary care settings. The PHQ-2 comprises the first 2 questions of the PHQ-9. METHODS: Consecutive adult patients attending Auckland family practices completed the PHQ-9, after which they completed the Composite International Diagnostic Interview (CIDI) depression reference standard. Sensitivities and specificities for PHQ-2 and PHQ-9 were analyzed. RESULTS: There were 2,642 patients who completed both the PHQ-9 and the CIDI. Sensitivity and specificity of the PHQ-2 for diagnosing major depression were 86% and 78%, respectively, with a score of 2 or higher and 61% and 92% with a score 3 or higher; for the PHQ-9, they were 74% and 91%, respectively, with a score of 10 or higher. For the PHQ-2 a score of 2 or higher detected more cases of depression than a score of 3 or higher. For the PHQ-9 a score of 10 or higher detected more cases of major depression than the PHQ determination of major depression originally described by Spitzer et al in 1999. CONCLUSIONS: We report the largest validation study of the PHQ-2 and PHQ-9, compared with a reference standard interview, undertaken in an exclusively primary care population. The PHQ-2 score or 2 or higher had good sensitivity but poor specificity in detecting major depression. Using a PHQ-2 threshold score of 2 or higher rather than 3 or higher resulted in more depressed patients being correctly identified. A PHQ-9 score of 10 or higher appears to detect more depressed patients than the originally described PHQ-9 scoring for major depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The PHQ-2 score was used to estimate the severity of depression, which assessed the frequency of depressed mood and anhedonia over the past two weeks [22].”
From Association between first-line antidepressant use and risk of dementia in older adults: a retrospective cohort study (2023) · cites this paper as [22]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The PHQ-8 has excellent internal consistency (Cronbach α=.89) and excellent test-retest reliability [47].”
From Feasibility and Preliminary Efficacy of Digital Interventions for Depressive Symptoms in Working Adults: Multiarm Randomized Controlled Trial (2023) · cites this paper as [47]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The PHQ-8 has excellent internal consistency (Cronbach α of .89 in primary care settings and .88 in this study at t0) and excellent test–retest reliability [49].”
From Feasibility and Preliminary Efficacy of Web-Based and Mobile Interventions for Common Mental Health Problems in Working Adults: Multi-Arm Randomized Pilot Trial (2022) · cites this paper as [49]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spitzer, R. L. (1999) · JAMA · doi:10.1001/jama.282.18.1737 · Cited by 9,802
The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2003) · Medical Care · doi:10.1097/01.mlr.0000093487.78664.3c · Cited by 6,359
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00010 · Cited by 3,219
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · BMJ · doi:10.1136/bmj.326.7379.41 · Cited by 3,215
Users' Guides to the Medical Literature
Guyatt, G. H. (1993) · JAMA · doi:10.1001/jama.270.17.2096 · Cited by 3,083
Detecting and monitoring depression with a two-item questionnaire (PHQ-2)
Löwe, B., Kroenke, K., & Gräfe, K. (2005) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2004.09.006 · Cited by 1,473
Wittchen, H.-U., Lachner, G., Wunderlich, U., & Pfister, H. (1998) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270050095 · Cited by 668
Spitzer, R. L., Williams, J. B. W., & Kroenke, K. (1999) · PsycTESTS Dataset · doi:10.1037/t02598-000 · Cited by 590
Screening for Depression: Recommendations and Rationale
U.S. Preventive Services Task Force* (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-10-200205210-00012 · Cited by 524
Li, C., Friedman, B., Conwell, Y., & Fiscella, K. A. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01103.x · Cited by 334
Research works printed but not linked: 3
- N Z Med J. 2003;116(1171):U379.
- Ministry of Health. Taking the Pulse. The 1996/97 New Zealand Health Survey. Wellington: Ministry of Health; 1999:197-202.
- Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
Cited by
Sorted by citations
Items 801–900 of 1,000
Au, M., Lipschutz, R. S., Mekawi, Y., Lathan, E. C., Dixon, H. D., Carter, S. E., Hinrichs, R. C., Bradley, B., Kaslow, N. J., Nugent, N. R., et al. (2024) · Journal of Mood and Anxiety Disorders · doi:10.1016/j.xjmad.2024.100092 · Cited by 7
“Questionnaire (PHQ-9, [18]).”
Madundo, K., Perry, M., Mwobobia, J. M., Shekibula, I., Msoka, E. F., Tarimo, C. S., Katiti, V. W., Mmbaga, B. T., Goldston, D. B., Relf, M. V., et al. (2025) · Frontiers in Health Services · doi:10.3389/frhs.2025.1557348 · Cited by 4
“This scale has been shown to have similar validity to the longer 9-item version of the PHQ while taking less time to administer (23).”
Rassir, R., Sierevelt, I. N., Schager, M., Nolte, P. A., the ATKOS group, Rademakers, M. V., Vergroesen, D. A., Spruijt, P., Baas, N. R. A., Sonnega, R. J. A., et al. (2021) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-021-04493-1 · Cited by 4
“The Patient Health Questionnaire (PHQ2) is a two-item questionnaire that is an accurate screening tool for major depressive disorders [41, 42].”
MethodCoughlin, L. N., Blow, F. C., Walton, M. A., Ignacio, R. V., Walters, H., Massey, L. S., Barry, K. L., & McCormick, R. (2021) · JMIR Mental Health · doi:10.2196/29397 · Cited by 4
“aOR: adjusted odds ratio BI: brief intervention EUC: enhanced usual care GAD: General Anxiety Disorder Questionnaire GLM: General linear modeling MINI: Mini International Neuropsychiatric Interview PHQ-9: Patient Health Questionnaire SIP: Short Index of Problems Edited by J Torous; submitted 05.04.21; peer-reviewed by…”
MethodInfluentialVillalobos-Gallegos, L., Trejo, S., Toledo-Fernández, A., & Ochoa-Ruiz, E. (2023) · Psychology Health & Medicine · doi:10.1080/13548506.2022.2163671 · Cited by 4
“It has shown good psychometric properties in several settings (Arroll et al., 2010; Wulsin et al., 2002), these studies also include Mexican population (Donlan & Lee, 2010; Familiar et al.”
BackgroundGalas, F. R. B. G., Fernandes, H. M., Franci, A., Rosário, A. L., Saretta, R., Patore, L., Baracioli, L., Moraes, J. G., Mourão, M. M., Costa, L. D. V., et al. (2023) · ASAIO Journal · doi:10.1097/mat.0000000000001919 · Cited by 4
Dijkstra, J. I. R., van Elteren, M., Banstola, N. L., Shakya, L., Sigdel, H., & van Brakel, W. H. (2024) · PLOS Global Public Health · doi:10.1371/journal.pgph.0002654 · Cited by 4
The association of ICUC trauma score and quick DASH in a distal radius fracture cohort
Liu, W., Hartwich, M., Locascio, J. J., Regazzoni, P., Jupiter, J. B., & Dell’Oca, A. F. (2024) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-024-04623-0 · Cited by 4
“…versions of other assessments, such as the Patient-Health Questionnaire-2 (PHQ-2) for assessing patient mental health, replacing the PHQ-9 [14], and the Pain Self-Efficacy Questionnaire-2 (PSEQ-2) to evaluate the psychometric effects of pain, using only 2 items instead of the original 10…”
MethodSex differences in unmet needs between male and female older Veterans
Garcia‐Davis, S., Tyagi, P., Bouldin, E. D., Hansen, J. L., Brintz, B. J., Noël, P. H., Rupper, R., TRIVEDI, R. B., Kinosian, B. P., Intrator, O. K., et al. (2024) · Journal of Women & Aging · doi:10.1080/08952841.2024.2375480 · Cited by 4
“Depression was measured using the Patient Health Questionnaire 2-item screener (PHQ-2) and anxiety using the Generalized Anxiety Disorder 2-item screener GAD-2 (Arroll et al., 2010; Plummer et al., 2016).”
Madundo, K., Mwobobia, J. M., Perry, M., Knippler, E. T., Amiri, I., Msoka, E. F., Tarimo, C. S., Katiti, V. W., Mmbaga, B. T., Goldston, D. B., et al. (2025) · PLOS mental health. · doi:10.1371/journal.pmen.0000268 · Cited by 4
“This scale has been shown to have similar validity to the longer 9-item version of the PHQ while taking less time to administer [25].”
Tabesh, M., Mirström, M., Böhme, R. A., Lasota, M., Javaherian, Y., Agbotsoka, T., & Sikström, S. (2025) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2025.103020 · Cited by 5
Montesinos‐Segura, R., Maticorena-Quevedo, J., Chung-Delgado, K., Pereyra‐Elías, R., Taype-Rondán, Á., & Mayta‐Tristán, P. (2018) · Rural and Remote Health · doi:10.22605/rrh4331 · Cited by 4
Thakarar, K., Walley, A. Y., Heeren, T., Winter, M. R., Ventura, A. S., Sullivan, M. M., Drainoni, M., & Saitz, R. (2019) · AIDS Care · doi:10.1080/09540121.2019.1683805 · Cited by 4
Nayak, R. B., Triptish Bhatia, A., Mahadevaiah, M., & Bheemappa, A. (2020) · Indian Journal of Psychological Medicine · doi:10.1177/0253717620972917 · Cited by 4
Oakley, G. M., Smith, K. A., Ashby, S., Orlandi, R. R., & Alt, J. A. (2021) · Annals of Otology Rhinology & Laryngology · doi:10.1177/00034894211005986 · Cited by 4
Kaur, K., Patel, V. K., Kumar, P., Vasavada, D. A., Nerli, L. M., & Tiwari, D. S. (2021) · Archives of Mental Health · doi:10.4103/amh.amh_72_20 · Cited by 4
Taylor, A. K., Palmer, V. J., Davidson, S. K., Fletcher, S. L., & Gunn, J. M. (2021) · Health & Social Care in the Community · doi:10.1111/hsc.13646 · Cited by 4
Self-citationPark, J., & Ahn, Y. (2022) · Public Performance & Management Review · doi:10.1080/15309576.2022.2137211 · Cited by 4
Addressing depressive disorders among people with HIV.
Fuenmayor, A., & Cournos, F. (2022) · PubMed Central · Cited by 4
Forkmann, T., Eimen, J., Plein, L., Höller, I., Böhler, L., Schönfelder, A., Hallensleben, N., Schreiber, D. S., Paashaus, L., Juckel, G., et al. (2024) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2024.100822 · Cited by 5
Chen, Z., Sinha, G. R., DeVylder, J., Mushonga, D. R., Mason, M. J., Fedina, L., & Amen, Z. (2024) · Social Work in Mental Health · doi:10.1080/15332985.2024.2377959 · Cited by 4
“Dependent variable of interest is depressive symptoms and is measured by the Patient Health Questionnaire-2 (PHQ-2, Arroll et al., 2010).”
Gómez–Restrepo, C., Peñaranda, A. P. B., Valencia, J. G., Guarín, M. R., Narváez, E. B., Jaramillo, L. E., Acosta, C. A. P., Pedraza, R. S., & Castro, S. (2012) · Revista Colombiana de Psiquiatría · doi:10.1016/s0034-7450(14)60044-5 · Cited by 4
Clinical Impact of Depression in Cirrhosis
Serigado, J. M., Barboza, K. C., Marcus, P., & Sigal, S. H. (2018) · Current Hepatology Reports · doi:10.1007/s11901-018-0386-x · Cited by 4
Weaver, A., Hahn, R. J., Tucker, K. M., Bybee, D. I., Yugo, K., Johnson, J. M., Buccalo, N., Pfeiffer, P., Kilbourne, A. M., & Himle, J. A. (2020) · Social Work in Mental Health · doi:10.1080/15332985.2020.1799907 · Cited by 4
Johnson, S. T., Mladenovic, A. B., Mathe, N., Davenport, M. H., Butalia, S., Qiu, W., & Johnson, J. A. (2017) · Contemporary Clinical Trials · doi:10.1016/j.cct.2017.07.008 · Cited by 6
Saquib, J., Alromaih, N., AlMutairi, H., Alenazi, R. N., Al-Mutairi, R. D. A., AlHtlani, D. J., Altheyab, F., Alhsaon, M. A., Imran, M., Khalaf, H., et al. (2018) · Journal of the Saudi Heart Association · doi:10.1016/j.jsha.2018.04.001 · Cited by 4
Lv, N., Xiao, L., Rosas, L. G., Venditti, E. M., Smyth, J. M., Lewis, M. A., Snowden, M. B., Ronneberg, C. R., Williams, L. M., Gerber, B. S., et al. (2021) · Annals of Behavioral Medicine · doi:10.1093/abm/kaaa125 · Cited by 4
“, nineitem Patient Health Questionnaire [PHQ-9] score ≥10) [21, 22].”
BackgroundFeliciano, L., Gum, A. M., & Johanson, K. A. (2019) · Springer eBooks · doi:10.1007/978-1-4939-9127-3_9 · Cited by 4
Toosi, M. (2016) · ScholarWorks (Walden University) · Cited by 4
Choi, K. W., Stein, M. B., Nishimi, K. M., Ge, T., Coleman, J. R. I., Chen, C., Ratanatharathorn, A. D., Zheutlin, A. B., Dunn, E. C., Breen, G. D., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/759753 · Cited by 4
Barkan, S. E., Rankin, L., Skinner, M. L., Orlando, L., Tajima, E. A., & Greenley, K. (2024) · Children and Youth Services Review · doi:10.1016/j.childyouth.2024.107531 · Cited by 3
Tong, S. T., Ma, K. P. K., Pleho, A., Keiser, B., Hsu, C., Ehde, D. M., Curran, M. C., Tsui, J. I., Raue, P. J., & Stephens, K. A. (2024) · Addiction Science & Clinical Practice · doi:10.1186/s13722-024-00498-y · Cited by 4
“Secondary outcomes Our other secondary outcomes include function [44], substance use [45, 46], social connection [47], depression [48], anxiety [49, 50], and prescribed opioid use.”
BackgroundMooren, E. S., Posthumus, A. G., Steensma, A. B., van der Kooy, J., & Speksnijder, L. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-101517 · Cited by 3
Lai, W. N., Tan, C. Y. F., Ong, C. Y., Wong, M. S. J., & Low, L. L. (2025) · Frontiers in Stroke · doi:10.3389/fstro.2025.1704636 · Cited by 3
Corso, M., Martin, K., Salmi, L., Wright, D. S., Quon, J., Cancelliere, C., Mior, S. A., Murnaghan, K., & Côté, P. (2025) · BMC Family Practice · doi:10.1186/s12875-025-03132-1 · Cited by 4
“…investigated the Patient Health Question-naire-9 (PHQ-9) [31, 33, 36, 37, 48, 49], three investigated the Patient Health Questionnaire-2 (PHQ-2) [31, 33, 37], one investigated each of the Generalised Anxiety Disorder 7-item (GAD-7) [38, 39], Generalised Anxiety Disorder 2-item (GAD-2) [38, 39],…”
InfluentialPalermo, T. M., Ohls, O. C., Dear, B. F., Doorenbos, A. Z., Yadav, D., Zhou, C., Bellin, M. D., Fisher, W., Fogel, E. L., Forsmark, C. E., et al. (2026) · Trials · doi:10.1186/s13063-026-09517-6 · Cited by 3
“The PROMIS Physical Functioning Short Form 6b [33] is a modified six-item measure assessing impairment in physical functioning X X X Psychological functioning Depressive symptoms will be assessed with the PHQ-9 [34].”
Lopez, J., & Thiamwong, L. (2026) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20260108-01 · Cited by 3
Associations Between Fear of Guilt and Obsessive–Compulsive Symptoms
Kenny, N. C., Starčević, V., & Berle, D. (2022) · Behaviour Change · doi:10.1017/bec.2022.14 · Cited by 3
Patients with fibromyalgia in Finnish healthcare center – one-year follow up
Järvinen, T., Varinen, A., & Sumanen, M. P. T. (2023) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2023.2259960 · Cited by 3
“The letter included FIQ, € OMPSQ, ACR 2010, EuroQol (EQ-5D-3L), and Patient Health Questionnaire (PHQ-9) in Finnish language [8,15–17].”
MethodWilliamson, G., Carr, E., Fear, N. T., Dymond, S., King, K., Simms, A., Goodwin, L., Murphy, D., & Leightley, D. (2023) · JMIR Research Protocols · doi:10.2196/51531 · Cited by 3
Toczyski, P., & Feliksiak, M. (2024) · Depression and Anxiety · doi:10.1155/2024/2241722 · Cited by 5
“Another study by Arroll et al. [2] validated the PHQ-2 and PHQ-9 as effective tools for screening for major depression in a primary care setting, with both scales showing high levels of accuracy and sensitivity.”
Mwanga, D. M., Odero, H. O., Kadengye, D. T., Odunga, S. A., Muluve, E., Mugotitsa, B., Wafubwa, R. N., Austrian, K., & Kiwuwa-Muyingo, S. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1469091 · Cited by 3
Ng, J. H., Abdullah, M. M., & Abdel‐Rahman, E. M. (2025) · Advances in Kidney Disease and Health · doi:10.1053/j.akdh.2024.10.001 · Cited by 3
Touzel, V., Reifegerste, D., Bozorgmehr, K., & Biddle, L. (2025) · SSM - Population Health · doi:10.1016/j.ssmph.2025.101822 · Cited by 4
“Both depression (PHQ-2) and anxiety (GAD-2) showed significant indirect associations via isolation, with mediation stronger for depression (e.g., high vs low SES: b = (cid:0) 0.0310, 95 % CI [ – 0.0521, (cid:0) 0.0098], p = 0.004) than for anxiety (high vs low SES: b = (cid:0) 0.0176, 95 % CI [ – 0.0324, (cid:0) 0.002…”
InfluentialA Love Supreme: Love’s Associations with Well-Being, Anxiety, Depression, and Spirituality
Marcovski, F. C. D. S., & Miller, L. (2025) · Religions · doi:10.3390/rel16060741 · Cited by 4
Vallée, G., Xi, D., Avramovic, G., O’Kelly, B., & Lambert, J. S. (2025) · PLoS ONE · doi:10.1371/journal.pone.0326790 · Cited by 8
“The PHQ-9 is scored from 0–27 and a score of ≥5 was used as a cut-off for symptoms of major depression [24,25].”
Flythe, J. E., Picataggio, C. B., Bernardo, L., Dalrymple, L. S., Kossmann, R. J., DeWalt, D. A., Hanson, L. C., Wang, V., Unruh, M. L., Hsu, J. Y., et al. (2025) · Contemporary Clinical Trials · doi:10.1016/j.cct.2025.108058 · Cited by 3
Low, C. C. H., Sung, S. C., Tan, A. K. H., Chan, Y. H., & Fung, D. S. S. (2019) · The Singapore Family Physician · doi:10.33591/sfp.44.2.o2 · Cited by 3
Trauma Screening Is More Common When Primary Care Patients Trust Providers
van den Berk‐Clark, C., & Renirie, T. (2021) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2021.04.004 · Cited by 3
Airdrie, J. N., Lievesley, A., & Griffith, E. (2021) · Advances in Dual Diagnosis · doi:10.1108/add-04-2021-0006 · Cited by 3
Pfeiffer, C., Schweda, A., Schüren, L. C., Niedergethmann, M., Steinbach, J., Rentrop, V., Robitzsch, A., Dörrie, N., Bäuerle, A., Teufel, M., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182010890 · Cited by 3
“Mental burdens during the previous two weeks were measured using the Patient Health Questionnaire-2 (PHQ8, measuring depression symptoms with two items on a four-point Likert Scale [28,29]) and the Generalized Anxiety Disorder-7 (GAD-7, measuring generalized anxiety using seven items on a four-point Likert Scale [30,3…”
MethodHinduan, Z. R., Wedyaswari, M., Reswara, I. P., & Setyowibowo, H. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.712806 · Cited by 4
“A total score of 15 or higher indicates moderate and severe major depression that can be an indicator for initiating a drug treatment (Arroll et al., 2010).”
BackgroundDey, M., Wenger, A., Baumgartner, C., Herrmann, U., Augsburger, M., Haug, S., Malischnig, D., & Schaub, M. P. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-03802-9 · Cited by 3
“A score of 10 or higher is considered indicative of a major depressive disorder [78].”
BackgroundBrawner, B. M., Talley, L. M., Baker, J. L., Bowleg, L., Dominique, T. B., Robinson, D. Y., Riegel, B. J., & Initiative, T. B. M. H. (2022) · Ethnicity & Disease · doi:10.18865/ed.32.3.169 · Cited by 3
Trujillo, C., Ferrari, G., Ngoga, G., McLaughlin, A., Davies, J., Tucker, A. A., Randolph, C., Cook, R. L., Park, P. H., Bukhman, G., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-060592 · Cited by 3
Nguyen, Y. P. H., Chau, P. T. M., Bui, M. X., Tran, N. A., Tran, N. T., Huynh, Q. N. H., Linh, N. T., & Huy, N. T. (2022) · Y HOC TP HO CHI MINH · doi:10.32895/ump.mpr.7.3.6 · Cited by 3
Psychosocial well‐being during the COVID‐19 pandemic among women with and without breast cancer
Pinheiro, L. C., Fasano, G. A., An, A., Mount, L., Bayard, S., Rosenberg, S. M., Taiwo, E. O., Loeb‐Zeitlin, S., Marti, J. L., Ashamalla, H. L., et al. (2023) · Psycho-Oncology · doi:10.1002/pon.6152 · Cited by 3
“Primary outcomes were psychosocial well‐being, including anxiety (assessed by Patient‐Reported Outcomes Measurement Information System [PROMIS]),(3,4) perceived stress (assessed by PROMIS),(3) and depression (assessed by Patient Health Questionnaire [PHQ9]).(5) Each outcome was considered separately.”
MethodDevelopment and Initial Validation of a Measure to Assess Self-Efficacy to Reduce Sedentary Behavior
Whipple, M. O., Bergouignan, A., & Hooker, S. A. (2023) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003215 · Cited by 3
Ho, E. Y., Karliner, L., Leung, G. Y., Harb, R., Ramirez, G. A., & Garcia, M. E. (2023) · Patient Education and Counseling · doi:10.1016/j.pec.2023.107850 · Cited by 3
Current Insights into the Use of Probiotics and Fatty Acids in Alleviating Depression
Gao, H., He, C., Xin, S., Hua, R., Du, Y., Wang, B., Gong, F., Yu, X., Pan, L., Gao, L., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11082018 · Cited by 3
“In primary care settings, a score of 2 or higher on the Patient Health Questionnaire 2 (PHQ-2) survey, which is widely utilized for diagnosis, has a sensitivity of 86% and a specificity of 78% [6].”
BackgroundKing, K., Leightley, D., Greenberg, N. L., & Fear, N. T. (2023) · JMIR Research Protocols · doi:10.2196/49918 · Cited by 4
Lifestyle Medicine Virtual Group Visits: Patient Attendance and Perceived Benefits
Mirsky, J. B., Brodney, S., Boratyn, V., & Thorndike, A. N. (2023) · American Journal of Lifestyle Medicine · doi:10.1177/15598276231208164 · Cited by 3
Baker, J. C., Bhola, S., Tabares, J. V., Beckman, D., Martin, C. G., Khazem, L. R., Bryan, A. O., & Bryan, C. J. (2023) · Military Medicine · doi:10.1093/milmed/usad200 · Cited by 3
Chatrath, S., Loiselle, A. R., Johnson, J. K., & Begolka, W. S. (2024) · Skin Health and Disease · doi:10.1002/ski2.408 · Cited by 5
Williamson, G., Trompeter, N., Murphy, D., Saba, S. K., Pedersen, E. R., Davis, J. P., & Leightley, D. (2024) · Mental Health Science · doi:10.1002/mhs2.75 · Cited by 3
Cao, T., Tian, M., Hu, H. H., Wu, H., Yu, Q., Su, X., Wang, R., Zhang, Q., An, Z., Song, J., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.07.063 · Cited by 3
Ye, B., Chen, Y., Ma, M., Liu, J., Tarimo, C. S., Han, S., Xue, K., Zuo, B., Wang, Y., & Song, Y. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-089486 · Cited by 3
Caregiver Depressive Symptoms Associated with Behavioral and Emotional Problems in Preschoolers
Fallucco, E. M., Greco, P., Aldridge, P. J., & Blackmore, E. R. (2019) · Journal of Child and Family Studies · doi:10.1007/s10826-019-01573-8 · Cited by 3
Development and validation of the hypersomnia-specific beliefs scale
Hazumi, M., Ito, W., Okubo, R., Wada, M., & Honda, M. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2020.06.012 · Cited by 3
VanderWall, R., Haefner, J., & Wehbe-Alamah, H. B. (2020) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000000494 · Cited by 3
“Scores of 20 or greater are usually indicative of severe depression (Arroll et al., 2010).”
BackgroundInfluentialAddressing depression and behavioral health needs through a digital program at scale
Sharif-Sidi, Z., Shen, C. P., Wong, W., Hanson, R., Miller, L. A., Fickel, K., Green, E., Burns, J., Dunn, C., Somai, M. M., et al. (2021) · Healthcare · doi:10.1016/j.hjdsi.2021.100521 · Cited by 3
An Ultra-Brief 2-Item Depression Screening Tool for Correctional Populations
Proctor, S. L., Hoffmann, N. G., & Kopak, A. M. (2021) · Journal of Correctional Health Care · doi:10.1089/jchc.19.06.0049 · Cited by 3
“…acceptable psychometric support for routine use in various noninstitutional community mental health and medical settings (e.g., Aben et al ., 2002; Arroll et al ., 2010; Beard et al ., 2016; Karim et al ., 2015; Watnick et al ., 2005), few have been developed and validated on correctional…”
Vaping, lung injury, and mental health Minnesota 2018-2019.
Cole, C., Wiens, T., Taylor, J., Danila, R., D’Heilly, P., Margetta, J., Bye, M., Mumm, E., Schwerzler, L., Makhtal, R., et al. (2021) · PubMed · Cited by 3
Diagnosis and Management of Perinatal Depression
Rossi, N. M., & Radney, L. (2022) · Nursing for Women s Health · doi:10.1016/j.nwh.2022.05.007 · Cited by 3
Odackal, J., Lyons, G. R., & Harris, D. A. (2019) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2019.1634684 · Cited by 3
“Prior studies demonstrate that a PHQ-9 score 10 has a sensitivity of 70–90% and specificity of 90% for the diagnosis of major depression (13,14).”
BackgroundRowan, N. R., Soler, Z. M., Mace, J. C., Camilon, M. P., Palmer, C., Jones, R. H., Smith, T. L., & Schlosser, R. J. (2020) · Rhinology Journal · doi:10.4193/rhin19.412 · Cited by 3
“(16–18) Meanwhile, the SF-6D instrument was used to detail current health states using a normalized health utility value,(19) the Patient Health Questionnaire-2 (PHQ-2) was used as a measure of depressive symptoms,(20) and the Pittsburgh Sleep Quality Index (PSQI) assessed participant sleep quality.”
MethodVillalobos-Gallegos, L., Medina‐Mora, M. E., Marín-Navarrete, R., Magis-Rodríguez, C. L., & Ruiz‐Velasco, S. (2020) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-020-00291-3 · Cited by 3
Parasar, K., Mohan, S., John, A. G., & Anand, U. (2021) · Cureus · doi:10.7759/cureus.13423 · Cited by 3
Patterns of opioid use after endoscopic sinus surgery among patients with anxiety and depression
Pandrangi, V. C., Scott, B. L., Pailet, J., Mace, J. C., Farrell, N. F., Geltzeiler, M. N., Smith, T. L., & Detwiller, K. Y. (2021) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22919 · Cited by 3
The Heart and Cannabis (THC) Cohort: Differences in Baseline Health and Behaviors by Cannabis Use
Keyhani, S., Cohen, B. E., Vali, M., Hoggatt, K. J., Bravata, D. M., Austin, P. C., Lum, E. N., Hasin, D. S., Grünfeld, C., & Shlipak, M. G. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-021-07302-6 · Cited by 3
Arrieta, J. (2015) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 3
Fusing Mobile Phone Sensing and Brain Imaging to Assess Depression in College StudentsPreprint
Huckins, J. F., daSilva, A. W., Wang, R., Wang, W., Hedlund, E. L., Murphy, E. I., Lopez, R. B., Rogers, C., Holtzheimer, P. E., Kelley, W. M., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/276568 · Cited by 3
Utilizing Telehealth Technology to Reduce Social Isolation and Depression in Seniors
Farrell, B. (2020) · doi:10.22371/07.2020.009 · Cited by 3
Baum, M., Druckman, J. N., Simonson, M. D., Lin, J. A.-J., & Perlis, R. H. (2021) · doi:10.31219/osf.io/tnfj7 · Cited by 3
“In our empirical investigations we primarily focus on the effects of severe depression (PHQ-9 ≥ 15), which is sometimes used as a threshold for referral to psychiatric treatment (Arroll et al. 2010).”
BackgroundUntangling the Puzzle of Digital Health Interventions
Simoski, B. (2022) · doi:10.5463/thesis.80 · Cited by 3
Long-COVID improves in 50% of patients after a year in a Midwestern cohortPreprint
Stalker, G., Tudas, R. A., Garg, A., Graham, L., Thurman, A. L., Wiblin, R. T., Hamzeh, N. Y., Blount, R. J., Villacreses, R. A., Zabner, J., et al. (2024) · medRxiv · doi:10.1101/2024.04.30.24306497 · Cited by 3
Boumparis, N., Noroozi, A., Naghizadeh, E., Meyer, A. A., Wenger, A., Rahimi‐Movaghar, A., & Schaub, M. P. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05007-0 · Cited by 2
“Secondary outcomes will be the longest period of abstinence for illicit, non-prescribed use of opioids (opium, heroin, tramadol) confirmed by urine samples; the number of self-reported other-streetdrug free days over the preceding 7 days (Timeline Follow Back method) [TLFB], [21]; the number of self-reported opioid-fr…”
MethodKhan, M. R., Acri, M. C., Ban, K. F., Scheidell, J. D., Stevens, E. R., Manandhar-Sasaki, P., Charles, D. L., Chichetto, N. E., Crystal, S., Gordon, A. J., et al. (2024) · AJPM Focus · doi:10.1016/j.focus.2024.100258 · Cited by 3
“38 In descriptive analyses, the authors examined participant correlates of mild depressive symptoms (PHQ-9 scores=1 − 9) versus elevated (moderate/severe) depressive symptoms (PHQ-9 score ≥ 10).”
BackgroundWambua, G. N., Stein, A. L., Seedat, S., Sijbrandij, M., Baisley, K. J., Shahmanesh, M., Seeley, J., & Ngwenya, N. B. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-088992 · Cited by 2
Hu, A., Liu, D. Y., Xie, H., Wu, X., Liu, K., Zhang, X., Li, L., Xing, Z., & Hu, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-74510-5 · Cited by 2
Hano, D., An, A., Nghiem, J., Koh, E. S., Tripathi, V., Wirtshafter, R., & Green, C. M. (2025) · Maternal and Child Health Journal · doi:10.1007/s10995-024-04037-8 · Cited by 2
“The PHQ-A is an expanded version of the PHQ-9 developed specifically for adolescents and includes addi - tional questions assessing persistent depressive disorder and suicide risk; it has demonstrated appropriate validity and reliability in assessing depressive symptoms among adolescents in the primary care setting, w…”
InfluentialTlachac, M., Reisch, M., Shrestha, A., Flores, R., Toto, E., & Rundensteiner, E. A. (2025) · ACM Transactions on Computing for Healthcare · doi:10.1145/3716315 · Cited by 3
“Collection 1 Train IDs: [ROSJJNIB3, CVCXR3FZV, 4IGU5ZQWZ, SGVN7E3SM, C4NCER7RE, G507LQZ5X, 18SVPE1ZJ, GZU3KNP1E,4IGB4DKMP,EE1MNQTUT,XRN7RMADR,ZNQ5Z1Q9I,QBEZBGLGH,U164N2SEN,HU0TL00AD,BS6OWRWT3, H8IBT4OV0,2W1EYGWM0,846CD4CAG,V8BP0D8P3,9RFJU57JW,YDYRIKI3H,8CLVULOIO,0FX9FNBH3,ZE5QAUQQL, ALJ5BW5DT,0NZH3ULXB,C06F1T857,9IS90…”
Challenges in Managing Depression in Clinical Practice: Result of a Global Survey
Kar, N. (2025) · Pharmacoepidemiology · doi:10.3390/pharma4010005 · Cited by 6
Lathan, E. C., Davydenko, I., Hosking, C., Rodriguez, D. C., Haynes, T., & Powers, A. D. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-12662-4 · Cited by 2
“Depressive symptoms are measured using the 9-item PHQ-9 [40].”
Liao, Y., Xiao, S., Zheng, X., Li, X., Xue, B., Yang, L., Zhang, M., Li, Q., Wu, Y., & Zhang, C. (2025) · BMC Public Health · doi:10.1186/s12889-025-22449-1 · Cited by 4
“The cutoff scores typically used to interpret PHQ-9 results are as follows: 0–4 represents the absence or minimal depressive symptoms, 5–9 indicates mild depressive symptoms, 10–14 reflects moderate depressive symptoms, and scores of 15 or above signify severe depressive symptoms [46].”
Murphy, M., Coventry, M. E., Rio, E., Chivers, P., Wand, B. M., Waddington, G. S., & Mosler, A. (2025) · Musculoskeletal Science and Practice · doi:10.1016/j.msksp.2025.103367 · Cited by 2
Guss, D. A., Gannon, R. B., Yang, Y., Navarro, S. P. P., & Norful, A. A. (2025) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000001201 · Cited by 2
Singh, H., Khan, M. F., Selvaraj, K., Dani, A., & Akkilagunta, S. (2025) · International Journal of Social Psychiatry · doi:10.1177/00207640251369135 · Cited by 2
“This tool has been effective with reasonably good sensitivity and specificity of 61% and 92% respectively for detecting major depression based on the cutoff score of 3 or greater in primary care patients (Arroll et al., 2010).”
Ingle, C., Anderson, R. E., & Williams, A. (2025) · Journal of Mental Health · doi:10.1080/09638237.2025.2558508 · Cited by 2
“The PHQ-2 is a validated measure that screens for Major Depressive Disorder and has been validated across the general population (Arrieta et al., 2017; Arroll et al., 2010).”
Batra, E. K., Tuan, W., Sekhar, D. L., Merai, R., Shi, T., & Fogel, B. N. (2025) · Journal of Primary Care & Community Health · doi:10.1177/21501319251374583 · Cited by 2
“Patient Health Questionnaire-2 (PHQ-2) The PHQ-2 is a brief, 2 question, validated depression screener 18,19 that inquires about symptoms in the last 2 weeks.”
Metadata
- Authors
- Arroll, B., Goodyear-Smith, F., Crengle, S., Gunn, J., Kerse, N., Fishman, T., Falloon, K., & Hatcher, S.
- Affiliations
- University of Auckland (NZ)
- Venue
- The Annals of Family Medicine
- Publisher
- Annals of Family Medicine
- Published
- 2010-07-01
- Volume
- 8
- Issue
- 4
- Pages
- 348-353
- ISSN
- 1544-1709 (ISSN-L)
- 1544-1717
- PMC
- PMC2906530
- OpenAlex
- W2122884679
- Cited by
- 1,279
- References
- 18
- Citations by year
- 2026: 60 · 2025: 89 · 2024: 115 · 2023: 115 · 2022: 137 · 2021: 182 · 2020: 116 · 2019: 92 · 2018: 71 · 2017: 63 · 2016: 60 · 2015: 55 · 2014: 39 · 2013: 42 · 2012: 23
- FWCI
- 34.75
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- The Annals of Family Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ResearchSpace (University of Auckland) (submittedVersion, cc-by)
- Funders
- Health Research Council of New Zealand
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- PHQ-2, PHQ-9, Patient Health Questionnaire, major depressive disorder, depression screening, primary care, screening sensitivity and specificity, Composite International Diagnostic Interview, threshold scores, general practice
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Major Depressive Disorder, Depressive Disorder, Major, Diagnosis, Computer-Assisted, Female, Humans, Male, Mass Screening, Middle Aged, New Zealand, Physicians, Family, Predictive Value of Tests, Primary Health Care, Psychometrics, Surveys and Questionnaires, Sensitivity and Specificity, Software, Time Factors, Prevalence, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review